DrugPatentWatch Database Preview
Pralsetinib - Generic Drug Details
» See Plans and Pricing
What are the generic sources for pralsetinib and what is the scope of patent protection?
Pralsetinib
is the generic ingredient in one branded drug marketed by Blueprint Medicines and is included in one NDA. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.Pralsetinib has twenty patent family members in nineteen countries.
Summary for pralsetinib
| International Patents: | 20 |
| US Patents: | 1 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Bulk Api Vendors: | 21 |
| Clinical Trials: | 1 |
| Patent Applications: | 18 |
| DailyMed Link: | pralsetinib at DailyMed |
Recent Clinical Trials for pralsetinib
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Blueprint Medicines Corporation | Phase 3 |
US Patents and Regulatory Information for pralsetinib
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Blueprint Medicines | GAVRETO | pralsetinib | CAPSULE;ORAL | 213721-001 | Sep 4, 2020 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
| Blueprint Medicines | GAVRETO | pralsetinib | CAPSULE;ORAL | 213721-001 | Sep 4, 2020 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
| Blueprint Medicines | GAVRETO | pralsetinib | CAPSULE;ORAL | 213721-001 | Sep 4, 2020 | RX | Yes | Yes | Start Trial | Start Trial | Y | Y | Start Trial | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for pralsetinib
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Hong Kong | 1259287 | Start Trial |
| Chile | 2018001181 | Start Trial |
| South Korea | 20180073689 | Start Trial |
| Australia | 2016348402 | Start Trial |
| Eurasian Patent Organization | 201891087 | Start Trial |
| Ecuador | SP18041935 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
